|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sleeckx N, Van Brantegem L, Van den Eynden
G, Fransen E, Casteleyn C, Van Cruchten S, Veldhuis Kroeze E and
Van Ginneken C: Angiogenesis in canine mammary tumours: A
morphometric and prognostic study. J Comp Pathol. 150:175–183.
2014. View Article : Google Scholar
|
|
3
|
Müller K, Ellenberger C, Hoppen HO and
Schoon HA: Immunohistochemical study of angiogenesis and angiogenic
factors in equine granulosa cell tumours. Res Vet Sci. 92:471–477.
2012. View Article : Google Scholar
|
|
4
|
Hoelder S, Clarke PA and Workman P:
Discovery of small molecule cancer drugs: Successes, challenges and
opportunities. Mol Oncol. 6:155–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ngo H, Tortorella SM, Ververis K and
Karagiannis TC: The Warburg effect: Molecular aspects and
therapeutic possibilities. Mol Biol Rep. 42:825–834. 2015.
View Article : Google Scholar
|
|
6
|
Bonavia R, Inda MM, Vandenberg S, Cheng
SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK and Furnari FB:
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB,
interleukin-8 pathway. Oncogene. 31:4054–4066. 2012. View Article : Google Scholar
|
|
7
|
Philip B, Ito K, Moreno-Sánchez R and
Ralph SJ: HIF expression and the role of hypoxic microenvironments
within primary tumours as protective sites driving cancer stem cell
renewal and metastatic progression. Carcinogenesis. 34:1699–1707.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Bock K, Georgiadou M, Schoors S,
Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquière B,
Cauwenberghs S, Eelen G, et al: Role of PFKFB3-driven glycolysis in
vessel sprouting. Cell. 154:651–663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doherty JR and Cleveland JL: Targeting
lactate metabolism for cancer therapeutics. J Clin Invest.
123:3685–3692. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Izumi H, Takahashi M, Uramoto H, Nakayama
Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S and Kohno K:
Monocarboxylate transporters 1 and 4 are involved in the invasion
activity of human lung cancer cells. Cancer Sci. 102:1007–1013.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge X, Lyu P, Cao Z, Li J, Guo G, Xia W and
Gu Y: Overexpression of miR-206 suppresses glycolysis,
proliferation and migration in breast cancer cells via PFKFB3
targeting. Biochem Biophys Res Commun. 463:1115–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bokhari M, Carnachan RJ, Cameron NR and
Przyborski SA: Culture of HepG2 liver cells on three dimensional
polystyrene scaffolds enhances cell structure and function during
toxicological challenge. J Anat. 211:567–576. 2007.PubMed/NCBI
|
|
13
|
Knight E and Przyborski S: Advances in 3D
cell culture technologies enabling tissue-like structures to be
created in vitro. J Anat. 227:746–756. 2015. View Article : Google Scholar
|
|
14
|
Huh D, Matthews BD, Mammoto A,
Montoya-Zavala M, Hsin HY and Ingber DE: Reconstituting organ-level
lung functions on a chip. Science. 328:1662–1668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi H, Jiang H, Wang L, Cao Y, Liu P, Xu
X, Wang Y, Sun L and Niu H: Overexpression of monocarboxylate anion
transporter 1 and 4 in T24-induced cancer-associated fibroblasts
regulates the progression of bladder cancer cells in a 3D
microfluidic device. Cell Cycle. 14:3058–3065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saad RS, El-Gohary Y, Memari E, Liu YL and
Silverman JF: Endoglin (CD105) and vascular endothelial growth
factor as prognostic markers in esophageal adenocarcinoma. Hum
Pathol. 36:955–961. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim C, Yang H, Fukushima Y, Saw PE, Lee J,
Park JS, Park I, Jung J, Kataoka H, Lee D, et al: Vascular RhoJ is
an effective and selective target for tumor angiogenesis and
vascular disruption. Cancer Cell. 25:102–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eelen G, Cruys B, Welti J, De Bock K and
Carmeliet P: Control of vessel sprouting by genetic and metabolic
determinants. Trends Endocrinol Metab. 24:589–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y,
Kinoshita J, Miyazaki M and Abe T: Estimation of angiogenesis with
anti-CD105 immunostaining in the process of colorectal cancer
development. Surgery. 131(Suppl): S109–S113. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saad R and Dabbs D: Endoglin, CD31, and
CD34 expression in the breast cancer. Laboratory Investigation.
Nature Publishing Group; New York, NY, USA: 2001
|
|
21
|
Saad RS, Jasnosz KM, Tung MY and Silverman
JF: Endoglin (CD105) expression in endometrial carcinoma. Int J
Gynecol Pathol. 22:248–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su J, Chen X and Kanekura T: A
CD147-targeting siRNA inhibits the proliferation, invasiveness, and
VEGF production of human malignant melanoma cells by downregulating
glycolysis. Cancer Lett. 273:140–147. 2009. View Article : Google Scholar
|
|
23
|
Carmeliet P, De Smet F, Loges S and
Mazzone M: Branching morphogenesis and antiangiogenesis candidates:
Tip cells lead the way. Nat Rev Clin Oncol. 6:315–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Y, An X, Guo X, Habtetsion TG, Wang Y,
Xu X, Kandala S, Li Q, Li H, Zhang C, et al: Endothelial PFKFB3
plays a critical role in angiogenesis. Arterioscler Thromb Vasc
Biol. 34:1231–1239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stapor P, Wang X, Goveia J, Moens S and
Carmeliet P: Angiogenesis revisited - role and therapeutic
potential of targeting endothelial metabolism. J Cell Sci.
127:4331–4341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rivera LB and Bergers G: Angiogenesis.
Targeting vascular sprouts. Science. 344:1449–1450. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Végran F, Boidot R, Michiels C, Sonveaux P
and Feron O: Lactate influx through the endothelial cell
monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway
that drives tumor angiogenesis. Cancer Res. 71:2550–2560. 2011.
View Article : Google Scholar
|
|
28
|
Schoors S, Cantelmo AR, Georgiadou M,
Stapor P, Wang X, Quaegebeur A, Cauwenberghs S, Wong BW, Bifari F,
Decimo I, et al: Incomplete and transitory decrease of glycolysis:
A new paradigm for anti-angiogenic therapy? Cell Cycle. 13:16–22.
2014. View
Article : Google Scholar :
|
|
29
|
Niu H, Jiang H, Cheng B, Li X, Dong Q,
Shao L, Liu S and Wang X: Stromal proteome expression profile and
muscle-invasive bladder cancer research. Cancer Cell Int.
12:392012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tennant DA, Durán RV and Gottlieb E:
Targeting metabolic transformation for cancer therapy. Nat Rev
Cancer. 10:267–277. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yi JH, Kim JH, Baek KK, Lim T, Lee DJ, Ahn
YC, Kim K, Kim SJ, Ko YH and Kim WS: Elevated LDH and paranasal
sinus involvement are risk factors for central nervous system
involvement in patients with peripheral T-cell lymphoma. Ann Oncol.
22:1636–1643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fahmueller YN, Nagel D, Hoffmann RT,
Tatsch K, Jakobs T, Stieber P and Holdenrieder S: Predictive and
prognostic value of circulating nucleosomes and serum biomarkers in
patients with metastasized colorectal cancer undergoing Selective
Internal Radiation Therapy. BMC Cancer. 12:52012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tas F, Aykan F, Alici S, Kaytan E, Aydiner
A and Topuz E: Prognostic factors in pancreatic carcinoma: Serum
LDH levels predict survival in metastatic disease. Am J Clin oncol.
24:547–550. 2001. View Article : Google Scholar
|
|
34
|
Murray CM, Hutchinson R, Bantick JR,
Belfield GP, Benjamin AD, Brazma D, Bundick RV, Cook ID, Craggs RI,
Edwards S, et al: Monocarboxylate transporter MCT1 is a target for
immunosuppression. Nat Chem Biol. 1:371–376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vander Heiden MG: Targeting cancer
metabolism: A therapeutic window opens. Nat Rev Drug Discov.
10:671–684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Le Floch R, Chiche J, Marchiq I, Naiken T,
Ilc K, Murray CM, Critchlow SE, Roux D, Simon M-P and Pouysségur J:
CD147 subunit of lactate/H+ symporters MCT1 and
hypoxia-inducible MCT4 is critical for energetics and growth of
glycolytic tumors. Proc Natl Acad Sci USA. 108:16663–16668. 2011.
View Article : Google Scholar
|
|
37
|
Chao JI, Su WC and Liu HF: Baicalein
induces cancer cell death and proliferation retardation by the
inhibition of CDC2 kinase and survivin associated with opposite
role of p38 mitogen-activated protein kinase and AKT. Mol Cancer
Ther. 6:3039–3048. 2007. View Article : Google Scholar : PubMed/NCBI
|
